Oncology Nursing News®

Blood Cancers

Consider These 3 Things Before Determining Myeloma Treatment

Consider These 3 Things Before Determining Myeloma Treatment

BY BRIELLE BENYON

FDA Grants CAR T-Cell Therapy a Priority Review for Large B-Cell Lymphoma

FDA Grants CAR T-Cell Therapy a Priority Review for Large B-Cell Lymphoma

BY BRIELLE BENYON

FDA Grants Priority Review to KTE-X19 for Treatment of Mantle Cell Lymphoma

FDA Grants Priority Review to KTE-X19 for Treatment of Mantle Cell Lymphoma

BY HANNAH SLATER

Updated Data Unveiled With Emerging Treatments in Myeloma

Updated Data Unveiled With Emerging Treatments in Myeloma

BY ELLIE LEICK

$FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma$

FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma

BY KRISTIE L. KAHL

Luspatercept Reduces Anemia in Patients With MDS

Luspatercept Reduces Anemia in Patients With MDS

BY BRITTANY COTE

After Years of Inactivity, AML Field Moves Forward

After Years of Inactivity, AML Field Moves Forward

BY ELLIE LEICK

ALL Field Continues to Progress, With CAR T-Cell and Other Therapies

ALL Field Continues to Progress, With CAR T-Cell and Other Therapies

BY JESSICA HERGERT

More Biosimilars Could Enter the Oncology Space

More Biosimilars Could Enter the Oncology Space

BY GINA COLUMBUS

There Are 'Tremendous Reasons to Be Hopeful' in Myeloma

There Are 'Tremendous Reasons to Be Hopeful' in Myeloma

BY SASCHA A. TUCHMAN, MD, MHS

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.